Table 2. Determinants of immune response.

	OR Non-adjusted [IC 95%]	OR adjusted [IC 95%]
Gender of ALWHIV
Male	Ref	Ref
Female	1.64 [0.69, 4.03]	2.03 [0.84, 5.14]
Participant family profile
Orphan by father	Ref	Ref
Orphan by mother	1.54 [0.33, 7.00]	1.8 [0.42, 7.74]
Orphan of both parents	1.22 [0.27, 5.36]	1.21 [0.28, 5.15]
Non-orphan	3.48 [0.86, 13.42]	3.63 [0.93, 13.81]
Treatment change
Yes	Ref	Ref
No	0.91 [0.20, 3.14]	1.08 [0.26, 3.72]
ART regimen
1st line	Ref	Ref
2nd line	0.34 [0.086,1.48]	0.26 [0.058, 1.17]
Missing doses
Yes	Ref	Ref
No	1.06 [0.43, 2.70]	0.91 [0.265, 3.71]
Duration on ART (years)
(1,5]	Ref
(5,9]	2.59 [0.92, 7.81]	3.73 [1.26, 12.21]
(9,16]	1.95 [0.65, 6.38]	3.98 [1.09, 16.6]

Legend. ALWHIV: adolescents living with HIV; ART: antiretroviral therapy.